艾迪康控股(09860)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09860 艾迪康控股

未开盘 09-02 16:08:05

3.705

+0.045

+1.23%

最高3.810	最低3.605	成交量11.60万
今开3.800	昨收3.660	日振幅5.60%
总市值26.90亿	流通市值26.90亿	总股本7.26亿
成交额43.86万	换手率0.02%	流通股本7.26亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09860","market":"HK","secType":"STK","nameCN":"艾迪康控股","latestPrice":3.705,"timestamp":1788336485872,"preClose":3.66,"halted":0,"volume":116000,"delay":0,"changeRate":0.012295081967213095,"floatShares":726000000,"shares":726000000,"eps":0.025812,"marketStatus":"未开盘","change":0.045,"latestTime":"09-02 16:08:05","open":3.8,"high":3.81,"low":3.605,"amount":438577,"amplitude":0.056011,"askPrice":3.685,"askSize":4500,"bidPrice":3.605,"bidSize":9500,"shortable":3,"etf":0,"ttmEps":0.037,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788399000000},"marketStatusCode":0,"adr":0,"listingDate":1688054400000,"exchange":"SEHK","adjPreClose":3.66,"openAndCloseTimeList":[[1788312600000,1788321600000],[1788325200000,1788336000000]],"volumeRatio":0.5400372438724342,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09860","defaultTab":"news","newsList":[{"id":"2662995769","title":"港股异动 | 艾迪康控股(09860.HK)一度跌超5% 上半年整体收入实现回升 整体平均售价仍具压力","url":"https://stock-news.laohu8.com/highlight/detail?id=2662995769","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662995769?lang=zh_cn&edition=full","pubTime":"2026-08-26 09:59","pubTimestamp":1787709570,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09860","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145505095","title":"艾迪康控股（09860）增聘馮丹龍為獨立非執行董事並調整薪酬委員會成員","url":"https://stock-news.laohu8.com/highlight/detail?id=1145505095","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145505095?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:07","pubTimestamp":1787648833,"startTime":"0","endTime":"0","summary":"艾迪康控股有限公司8月25日公告稱，董事會已通過委任馮丹龍女士為獨立非執行董事，自2026年8月25日起生效。公司同日調整董事會薪酬委員會組成，馮丹龍將出任薪酬委員會成員；張煒先生已辭任該委員會成員職務。截至公告日期，艾迪康控股董事會組成如下：執行董事王樂剛先生；非執行董事楊凌女士、林繼迅先生、李波先生、周敏濤先生；獨立非執行董事宓子厚先生、葉霖先生、張煒先生及馮丹龍女士。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09860"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153466593","title":"艾迪康控股（09860）完成公司秘书资格过渡　王之翰豁免期届满符合资质 新旧联席公司秘书交替","url":"https://stock-news.laohu8.com/highlight/detail?id=1153466593","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153466593?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:06","pubTimestamp":1787648779,"startTime":"0","endTime":"0","summary":"8月25日，艾迪康控股有限公司公告称，香港联交所已确认王之翰自2026年6月29日豁免期届满后，符合《上市规则》第3.28及第8.17条所规定的公司秘书资格要求，公司无须再就其任职申请进一步豁免。为持续维持双秘书架构，公司将沿用联席公司秘书安排。同日，董事会披露，因个人工作安排，苏嘉敏已辞任联席公司秘书，辞任自2026年8月25日起生效。苏嘉敏确认与董事会并无意见分歧，也无任何与其离任有关的事宜需提请股东或联交所关注。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09860"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161773313","title":"艾迪康控股（09860）公布董事会及四大专门委员会最新架构","url":"https://stock-news.laohu8.com/highlight/detail?id=1161773313","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161773313?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:05","pubTimestamp":1787648743,"startTime":"0","endTime":"0","summary":"香港，2026年8月25日—ADICON Holdings Limited于今日公告董事会成员及其在四大专门委员会中的最新角色与职能分工。公告显示，公司董事会及其专门委员会的架构已明确，并覆盖审核、薪酬、提名及战略等关键职能，为公司治理奠定组织基础。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09860"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662299787","title":"艾迪康控股(09860)：冯丹龙获委任为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2662299787","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662299787?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:04","pubTimestamp":1787648666,"startTime":"0","endTime":"0","summary":"智通财经APP讯，艾迪康控股(09860)发布公告，冯丹龙女士已获委任为独立非执行董事，自2026年8月25日起生效。自2026年8月25日起，张炜先生已辞任董事会薪酬委员会成员，冯女士进一步获委任为董事会薪酬委员会成员。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485059.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09860","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168853668","title":"艾迪康控股(09860)发布2026年中期业绩：营收12.85亿元 净利同比增23.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168853668","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168853668?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:03","pubTimestamp":1787648618,"startTime":"0","endTime":"0","summary":"2026年8月25日，艾迪康控股有限公司公布截至2026年6月30日止六个月未经审计中期业绩。报告期内，公司实现收益12.85亿元，同比增长1.1%；毛利4.87亿元，同比增长7.2%；毛利率37.9%，较上年同期提升2.1个百分点；归属于母公司股东的净利润3,200.6万元，较上年同期的2,727.3万元增长17.3%；期内溢利3,526.7万元，同比增长23.4%。每股基本及摊薄盈利均为0.04元。公司上半年集团毛利率提升至37.9%，较2025年同期提高逾200个基点。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09860"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662787211","title":"艾迪康控股(09860)发布中期业绩，归母溢利3200.6万元 同比增加17.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662787211","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662787211?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:02","pubTimestamp":1787648571,"startTime":"0","endTime":"0","summary":"智通财经APP讯，艾迪康控股(09860)发布截至2026年6月30日止6个月的中期业绩，该集团取得收益人民币12.85亿元(单位下同)，同比增加1.12%;母公司拥有人应占溢利3200.6万元，同比增加17.35%;每股盈利0.04元。公告称，收益增加乃主要由于销量增长有所改善，尽管与医保报销相关的定价压力持续存在但正逐步缓解，两者综合影响促使今年上半年整体收入实现回升。集团持续观察到，今年以来行业状况正不断改善。集团的业务量增长得益于对集团特检业务、共建业务及CRO业务的持续投入，以及销售团队在拓展新客户方面的持续推动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485053.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09860","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178084342","title":"艾迪康控股（09860）拟于8月25日召开董事会审议2026年中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1178084342","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178084342?lang=zh_cn&edition=full","pubTime":"2026-08-13 16:55","pubTimestamp":1786611356,"startTime":"0","endTime":"0","summary":"艾迪康控股有限公司（09860）8月13日公告称，公司董事会拟于2026年8月25日（星期二）召开会议，议程包括审议及批准刊发集团截至2026年6月30日止六个月的未经审计综合中期业绩公告。\n公告显示，董事会目前由8名董事组成，包括执行董事1名、非执行董事4名及独立非执行董事3名。\n公司未在本次公告中披露任何财务数据，相关中期业绩将在董事会审议通过后对外发布。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09860"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190180600","title":"艾迪康控股公布2026年7月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1190180600","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190180600?lang=zh_cn&edition=full","pubTime":"2026-08-05 16:46","pubTimestamp":1785919619,"startTime":"0","endTime":"0","summary":"艾迪康控股于2026年8月5日发布截至2026年7月31日止的股份变动月报表。报告显示，公司本月注册股本维持2,500,000,000股普通股，面值每股0.00002美元，法定注册股本保持50,000美元，与上月一致。与上月相比，已发行股份数及库藏股份数均无变动。公司于本月内并未进行股份发行、购回及注销活动，也无其他类股份或股权激励计划变动。公司在月报中确认，其已符合适用的最低公众持股量25%的合规要求，整体股本结构保持稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09860"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110863077","title":"艾迪康控股更新6月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1110863077","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1110863077?lang=zh_cn&edition=full","pubTime":"2026-07-03 17:12","pubTimestamp":1783069977,"startTime":"0","endTime":"0","summary":"艾迪康控股有限公司于2026年7月3日发布截至2026年6月30日的月度证券变动报告。公告显示，公司法定股本保持不变，注册股本总额为50,000美元，对应2,500,000,000股普通股，每股面值0.00002美元。报告期内已发行股份为725,643,291股，库存股份为1,617,000股，已发行股份总数为727,260,291股，较上月无新增发行或回购注销，股本总体维持稳定。截至本报告期末，公司确认维持足够的公众持股量，符合香港联交所《上市规则》的最低要求。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09860"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130043028","title":"艾迪康控股5月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1130043028","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130043028?lang=zh_cn&edition=full","pubTime":"2026-06-02 19:15","pubTimestamp":1780398959,"startTime":"0","endTime":"0","summary":"艾迪康控股有限公司于2026年6月2日发布截至2026年5月31日的证券变动月报表。公告显示，公司本月无新增发行或股份变动，股本保持稳定。根据报告，艾迪康控股有限公司的注册股本仍为2,500,000,000股普通股，每股面值为0.00002美元，对应法定/注册股本总额50,000美元，与上月一致。公告显示，本月无股份期权、权证或可换股票据的增减情况，也无其他涉及公司已发行股份的承诺发行协议或回购注销活动。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09860"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638350854","title":"艾迪康控股(09860)：叶霖获指定为首席独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2638350854","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638350854?lang=zh_cn&edition=full","pubTime":"2026-05-27 16:35","pubTimestamp":1779870929,"startTime":"0","endTime":"0","summary":"智通财经APP讯，艾迪康控股(09860)公布，独立非执行董事叶霖先生已获指定为首席独立非执行董事，自2026年5月27日起生效。叶霖先生现为董事会审核委员会主席及提名委员会成员。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446575.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","09860"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162098672","title":"艾迪康控股2026年4月股份变动月报表：股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1162098672","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162098672?lang=zh_cn&edition=full","pubTime":"2026-05-04 18:08","pubTimestamp":1777889284,"startTime":"0","endTime":"0","summary":"艾迪康控股有限公司于2026年5月4日公告了其2026年4月股份变动月报表。本次披露的报告期为2026年4月，报告涵盖截至4月30日的股份及相关情况。已发行普通股数量仍为725,643,291股，库存股数量为1,617,000股，合计727,260,291股，与上月相比无新增发行、购回、注销及其他变动。本次月报由联席公司秘书王之翰、苏嘉敏签署。公司确认，所有已发行股份及库存股相关事宜均按照监管及法律要求进行，股本总体维持不变。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09860"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152980503","title":"艾迪康控股2026年3月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1152980503","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152980503?lang=zh_cn&edition=full","pubTime":"2026-04-08 16:45","pubTimestamp":1775637944,"startTime":"0","endTime":"0","summary":"艾迪康控股有限公司（股票代码：09860）于2026年4月8日发布截至2026年3月31日的股份变动月报表。公告显示，公司报告期内法定注册股本为2,500,000,000股，面值USD 0.00002，总额USD 50,000；期末已发行股份（不含库存股份）725,643,291股，库存股份1,617,000股，合计727,260,291股，较上月无任何增减变化。\n公司在报告期内未有新增发行、购回或注销股份，股本结构保持稳定，亦确认满足香港联交所规定的公众持股量要求。公司同时声明遵守香港联交所《上市规则》及相关法律法规。\n本次公告由联席公司秘书王之翰、苏嘉敏签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09860"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623581433","title":"港股异动|艾迪康控股(09860)收涨逾25% 富瑞金融维持“买入”并给予目标价7港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2623581433","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2623581433?lang=zh_cn&edition=full","pubTime":"2026-03-31 20:39","pubTimestamp":1774960754,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周二，艾迪康控股盘中飙涨，当日收涨25.75%。消息面上，3月30日，投行富瑞金融在研报中维持艾迪康控股“买入”评级，更新目标价至7.00港元，较前一交易日收盘价3.43港元有104%的上涨空间。该行在报告中指出，艾迪康在独立临床实验室发展中以AI为核心发力方向。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423271.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","159940","09860","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622069886","title":"ICL行业调整之年，艾迪康（09860）何以率先突围？","url":"https://stock-news.laohu8.com/highlight/detail?id=2622069886","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2622069886?lang=zh_cn&edition=full","pubTime":"2026-03-26 08:43","pubTimestamp":1774485792,"startTime":"0","endTime":"0","summary":"以刚刚披露2025年业绩的艾迪康控股为例，2025年，公司实现收入26.4亿元，经调整净利为6607万元，在行业普遍承压的背景下，经营基本盘展现出超预期的稳健性。分业务来看，公司传统ICL业务稳健运行，共建业务收入同比增长约20%，成为夯实基本盘的重要支撑。小结站在2026年的新起点上，艾迪康交出的这份2025年成绩单，不仅展现了其在行业调整周期中的经营韧性，更印证了“ICL+CRO”双轮驱动战略的前瞻性与有效性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419212.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4093","ICL","09860","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622026891","title":"艾迪康控股(09860)发布年度业绩 股东应占溢利1844.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2622026891","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2622026891?lang=zh_cn&edition=full","pubTime":"2026-03-25 16:42","pubTimestamp":1774428141,"startTime":"0","endTime":"0","summary":"智通财经APP讯，艾迪康控股 发布截至2025年12月31日止年度的全年业绩，该集团期内取得收益26.38亿元;母公司拥有人应占溢利1844.3万元;每股基本盈利0.03元。投标方面，公司持续完善投标团队体系化建设，中标总额达6.7亿元，市场机会覆盖率达67%，重点客户保留率达91%。同时，公立三级医院中标数同比增长32%，公立二级医院中标数同比增长21%。展望未来，公司将进一步深化投标精细化管理，不断提升市场竞争力，全力抢抓优质业务机遇。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418704.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","09860"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619458173","title":"港股异动 | 艾迪康控股(09860)收涨近7% 近期与高博医疗集团达成深度战略合作 公司有望开启估值修复","url":"https://stock-news.laohu8.com/highlight/detail?id=2619458173","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2619458173?lang=zh_cn&edition=full","pubTime":"2026-03-16 16:14","pubTimestamp":1773648842,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，艾迪康控股收涨近7%，截至发稿，涨6.73%，报4.76港元，成交额156.2万港元。消息面上，本月初，艾迪康与高博医疗集团正式签署战略合作协议。此次艾迪康与高博医疗集团的战略合作，是第三方医学检验机构与研究型医疗集团的一次重要跨界融合，也是艾迪康深化“技术+服务+生态”三位一体发展路径的关键举措。值得注意的是，3月9日，艾迪康控股退通利空出尽、资金回流有望推动股价开启估值修复。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414282.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","VXUS","BK1219","BK4588","09860","159891"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618417129","title":"每日卖空追踪 | 艾迪康控股 03月11日卖空量成交1500股，卖空比例为0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618417129","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2618417129?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:30","pubTimestamp":1773217842,"startTime":"0","endTime":"0","summary":"艾迪康控股北京时间03月11日，跌8.72%，卖空量成交1500股，较上一交易日减少97.95%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163629a460b8ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163629a460b8ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1219","09860"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618417489","title":"艾迪康控股盘中异动 快速跳水5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618417489","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2618417489?lang=zh_cn&edition=full","pubTime":"2026-03-11 14:54","pubTimestamp":1773212095,"startTime":"0","endTime":"0","summary":"2026年03月11日下午盘14时54分，艾迪康控股股票出现波动，股价快速下挫5.07%。截至发稿，该股报4.680港元/股，成交量36.65万股，换手率0.05%，振幅7.71%。艾迪康控股股票所在的医疗及医学美容服务行业中，整体涨幅为0.01%。其相关个股中，金威医疗、德斯控股、麦迪卫康涨幅较大，振幅较大的相关个股有金威医疗、梅斯健康、康健国际医疗，振幅分别为27.72%、10.00%、8.00%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031114545595482bec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031114545595482bec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09860","BK1219"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.adicon.com.cn","stockEarnings":[{"period":"1week","weight":0.0349},{"period":"1month","weight":0.133},{"period":"3month","weight":-0.012},{"period":"6month","weight":-0.2678},{"period":"1year","weight":-0.4854},{"period":"ytd","weight":-0.1241}],"compareEarnings":[{"period":"1week","weight":-0.0133},{"period":"1month","weight":-0.0268},{"period":"3month","weight":0.0023},{"period":"6month","weight":-0.0173},{"period":"1year","weight":-0.0073},{"period":"ytd","weight":-0.0125}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"艾迪康控股有限公司是一家主要提供独立医学实验室（ICL）的控股公司。该公司提供医学检验、临床试验、科研服务、健康管理及病理会诊服务。该公司重点发展感染性疾病、妇女健康、实体肿瘤、围产&儿童中心、血液等核心疾病领域，覆盖内科、儿科、妇产科、肿瘤科、神经科等众多科目。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.092907},{"month":2,"riseRate":0.666667,"avgChangeRate":0.149857},{"month":3,"riseRate":0,"avgChangeRate":-0.093822},{"month":4,"riseRate":0,"avgChangeRate":-0.023527},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.109041},{"month":6,"riseRate":0.666667,"avgChangeRate":0.073514},{"month":7,"riseRate":0.25,"avgChangeRate":-0.060406},{"month":8,"riseRate":0.5,"avgChangeRate":0.059119},{"month":9,"riseRate":0.5,"avgChangeRate":0.007916},{"month":10,"riseRate":0,"avgChangeRate":-0.240195},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.052882},{"month":12,"riseRate":0.666667,"avgChangeRate":0.14091}],"exchange":"SEHK","name":"艾迪康控股","nameEN":"ADICON HOLDINGS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾迪康控股(09860)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾迪康控股(09860)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾迪康控股,09860,艾迪康控股股票,艾迪康控股股票老虎,艾迪康控股股票老虎国际,艾迪康控股行情,艾迪康控股股票行情,艾迪康控股股价,艾迪康控股股市,艾迪康控股股票价格,艾迪康控股股票交易,艾迪康控股股票购买,艾迪康控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾迪康控股(09860)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾迪康控股(09860)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}